Omata M - Search Results

1

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial.

Omata M, Nishiguchi S, Ueno Y, Mochizuki H, Izumi N, Ikeda F, Toyoda H, Yokosuka O, Nirei K, Genda T, Umemura T, Takehara T, Sakamoto N, Nishigaki Y, Nakane K, Toda N, Ide T, Yanase M, Hino K, Gao B, Garrison KL, Dvory-Sobol H, Ishizaki A, Omote M, Brainard D, Knox S, Symonds WT, McHutchison JG, Yatsuhashi H, Mizokami M. Omata M, et al. J Viral Hepat. 2014 Nov;21(11):762-8. doi: 10.1111/jvh.12312. Epub 2014 Sep 8. J Viral Hepat. 2014. PMID: 25196837 Clinical Trial.

2

Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.

Yokosuka O, Ito Y, Imazeki F, Ohto M, Omata M. Yokosuka O, et al. Among authors: omata m. Biochem Biophys Res Commun. 1992 Nov 30;189(1):565-71. doi: 10.1016/0006-291x(92)91595-h. Biochem Biophys Res Commun. 1992. PMID: 1280430

3

Non-A, non-B chronic hepatitis is chronic hepatitis C: a sensitive assay for detection of hepatitis C virus RNA in the liver.

Hosoda K, Omata M, Yokosuka O, Kato N, Ohto M. Hosoda K, et al. Among authors: omata m. Hepatology. 1992 May;15(5):777-81. doi: 10.1002/hep.1840150506. Hepatology. 1992. PMID: 1314769

4

Nucleotide sequences of 5-1-1 of hepatitis C virus in patients with chronic liver disease.

Hosoda K, Omata M, Yokosuka O, Kato N, Ohto M. Hosoda K, et al. Among authors: omata m. Gastroenterology. 1992 Mar;102(3):1039-43. doi: 10.1016/0016-5085(92)90194-4. Gastroenterology. 1992. PMID: 1371485

5

Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.

Takano S, Omata M, Yokosuka O, Imazeki F, Ohto M. Takano S, et al. Among authors: omata m. Dig Dis Sci. 1992 Nov;37(11):1633-43. doi: 10.1007/BF01299851. Dig Dis Sci. 1992. PMID: 1425062

6

Detection and partial sequencing of hepatitis C virus RNA in the liver.

Hosoda K, Yokosuka O, Omata M, Kato N, Ohto M. Hosoda K, et al. Among authors: omata m. Gastroenterology. 1991 Sep;101(3):766-71. doi: 10.1016/0016-5085(91)90537-u. Gastroenterology. 1991. PMID: 1650319

7

Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.

Omata M, Ito Y, Yokosuka O, Imazeki F, Tagawa M, Takano S, Hosoda K, Tada M, Ohto M, Ito K, et al. Omata M, et al. Dig Dis Sci. 1991 Sep;36(9):1217-22. doi: 10.1007/BF01307512. Dig Dis Sci. 1991. PMID: 1654240 Clinical Trial.

8

Resolution of acute hepatitis C after therapy with natural beta interferon.

Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, Tada M, Ito Y, Ohto M. Omata M, et al. Lancet. 1991 Oct 12;338(8772):914-5. doi: 10.1016/0140-6736(91)91774-o. Lancet. 1991. PMID: 1681268 Clinical Trial.

9

Hepatitis C virus infection and antiviral treatment.

Omata M, Yokosuka O, Hosoda K, Kato N, Ito Y, Ohto M. Omata M, et al. Gastroenterol Jpn. 1991 Jul;26 Suppl 3:230-3. doi: 10.1007/BF02779307. Gastroenterol Jpn. 1991. PMID: 1715832 No abstract available.

10

Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection.

Ehata T, Omata M, Yokosuka O, Hosoda K, Ohto M. Ehata T, et al. Among authors: omata m. J Clin Invest. 1992 Jan;89(1):332-8. doi: 10.1172/JCI115581. J Clin Invest. 1992. PMID: 1729279 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,294 results

Search Page

Filters